Anileridine
(Redirected from Leritin)
Synthetic opioid analgesic
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
Anileridine is a synthetic opioid analgesic that is structurally related to pethidine (meperidine). It was developed in the 1950s by the pharmaceutical company Merck & Co. as a potential alternative to pethidine with a better side effect profile.
Pharmacology[edit | edit source]
Anileridine works by binding to the opioid receptors in the central nervous system, which leads to the inhibition of pain signals. It is primarily used for the management of moderate to severe pain. The drug has a similar mechanism of action to other opioids, such as morphine and fentanyl, but with some differences in its pharmacokinetic properties.
Medical Uses[edit | edit source]
Anileridine is indicated for the relief of moderate to severe pain. It is often used in a hospital setting for postoperative pain management and in patients who require continuous pain relief. The drug can be administered orally or via intravenous injection.
Side Effects[edit | edit source]
Common side effects of anileridine include nausea, vomiting, dizziness, and constipation. Like other opioids, it has the potential for abuse and dependence. Overdose can lead to severe respiratory depression and death.
Legal Status[edit | edit source]
Anileridine is classified as a controlled substance in many countries due to its potential for abuse and dependence. In the United States, it is listed as a Schedule II controlled substance under the Controlled Substances Act.
History[edit | edit source]
Anileridine was first synthesized in the 1950s by Merck & Co. It was introduced as a potential alternative to pethidine, with the aim of providing effective pain relief with fewer side effects. However, its use has declined over the years with the development of newer analgesics.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
